What question did this study set out to answer?

The aim is to evaluate the role of NQO1 in chemotherapy resistance in cholangiocarcinoma (CCA).

Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents

View Full Paper

Ask AI

Bookmark

The aim is to evaluate the role of NQO1 in chemotherapy resistance in cholangiocarcinoma (CCA).
Two CCA cell lines, KKU-100 and KKU-M214, were used to assess sensitivity to 5-FU, Doxo, and Gem.
NQO1 and/or p53 expression was modulated using siRNA or transfection techniques.
Cytotoxicity was measured using SRB assay, and Western blot analysis evaluated underlying mechanisms.
NQO1 knockdown in KKU-100 increased sensitivity to all tested chemotherapeutic agents.
Overexpression of NQO1 in KKU-M214 resulted in increased resistance to these agents.
Enhanced chemosensitivity from NQO1 silencing was linked to p53-mediated cell death, which was reversed by p53 knockdown.

No takes yet. Share an insight, caveat, or question.

Randomized trial demonstrates enhanced chemosensitivity in cholangiocarcinoma following NQO1 inhibition, suggesting a potential therapeutic approach.

Zeekpudsa et al. (2014) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial demonstrates enhanced chemosensitivity in cholangiocarcinoma following NQO1 inhibition, suggesting a potential therapeutic approach.